Trial · NCT03175367
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent Change From Baseline in Calculated Low Density Lipoprotein Cholesterol (LDL-C) at Week 16 (Intent-to-Treat [ITT] Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Apolipoprotein B (Apo B) at Week 16 (ITT Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Apo B at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Non High Density Lipoprotein Cholesterol (Non-HDL-C) at Week 16 (ITT Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Non-HDL-C at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percentage of Participants With >= 30% Reduction in Calculated LDL-C at Week 16 (ITT Estimand) | Week 16 | Percentage of Participants | NUMBER | |
| SECONDARY | Percentage of Participants With >= 50% Reduction in Calculated LDL-C at Week 16 (ITT Estimand) | Week 16 | Percentage of Participants | NUMBER | |
| SECONDARY | Percentage of Participants With Calculated LDL-C < 50 mg/dL (1.30 mmol/L) at Week 16 (ITT Estimand) | Week 16 | Percentage of Participants | NUMBER | |
| SECONDARY | Percent Change From Baseline in Calculated LDL-C at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Total Cholesterol (TC) at Week 16 (ITT Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Total Cholesterol at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Fasting Triglycerides at Week 16 (ITT Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Fasting Triglycerides at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Lipoprotein a [Lp(a)] at Week 16 (ITT Estimand) | Baseline and Week 16 | Percent Change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change From Baseline in Lipoprotein (a) [Lp(a)] at Week 24 (ITT Estimand) | Baseline and Week 24 | Percent Change | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03175367/outcomes